Pembrolizumab-induced immune-mediated fatal colitis with concurrent giardia infection

Sadeleştirilmiş öğe sayfası
dc.contributor.authorSisman, Gurhan
dc.contributor.authorBarbur, Erol
dc.contributor.authorSaka, Didem
dc.contributor.authorErdamar Cetin, Sibel
dc.date.accessioned2025-10-16T15:19:53Z
dc.date.issued2021
dc.identifier.doi10.1007/s00262-020-02815-1
dc.identifier.otherWOS:000609964900002
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/7424
dc.publisherSPRINGER
dc.sourceCANCER IMMUNOLOGY IMMUNOTHERAPY
dc.subjectCell\\-mediated immunity
dc.subjectColitis
dc.subjectColonoscopy
dc.subjectDrug side effects
dc.subjectImmunotherapy
dc.subjectMedical oncology
dc.titlePembrolizumab-induced immune-mediated fatal colitis with concurrent giardia infection
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS